| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. | Anchalee Techasen Watcharin Loilome Nisana Namwat Eri Takahashi Eiji Sugihara Anucha Puapairoj Masanao Miwa Hideyuki Saya Puangrat Yongvanit |
2010 | ||||
| 2. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | N. Namwat J. Puetkasichonpasutha W. Loilome P. Yongvanit A. Techasen A. Puapairoj B. Sripa W. Tassaneeyakul N. Khuntikeo S. Wongkham |
2011 | ||||
| 3. | Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. | Jurairat Jongthawin Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Nisana Namwat |
2012 | ||||
| 4. | Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells | Techasen, A Loilome, W Namwat, N Dokduang, H Jongthawin, J Yongvanit, P |
2012 | ||||
| 5. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma | N. Namwat P. Chusorn W. Loilome A. Techasen J. Puetkasichonpasutha C. Pairojkul N. Khuntikeo P. Yongvanit |
2012 | ||||
| 6. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. | Watcharin Loilome Sasithorn Kadsanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Ananya Dechakhamphu Chadamas Pinitsoontorn Puangrat Yongvanit |
2012 | ||||
| 7. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Puangrat Yongvanit Raynoo Thanan Somchai Pinlaor Paiboon Sithithaworn Watcharin Loilome Nisana Namwat Anchalee Techasen Somkid Dechakhamphu |
2012 | ||||
| 8. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. | Techasen, A. Loilome, W. Namwat, N. Duenngai, K. Cha'on, U. Thanan, R. Sithithaworn, P. Miwa, M. Yongvanit, P. |
2012 | ||||
| 9. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. | Anchalee Techasen Nisana Namwat Watcharin Loilome Pornpan Bungkanjana Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2012 | ||||
| 10. | Annexin A1: A new immunohistological marker of cholangiocarcinoma | Hongsrichan, N Rucksaken, R Chamgramol, Y Pinlaor, P Techasen, A Yongvanit, P Khuntikeo, N Pairojkul, C Pinlaor, S |
2013 | ||||
| 11. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. | Apinya Jusakul Watcharin Loilome Nisana Namwat Anchalee Techasen Rahul Kuver George N. Ioannou Christopher Savard W. Geoffrey Haigh Puangrat Yongvanit |
2013 | ||||
| 12. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Yothaisong, S Dokduang, H Techasen, A Namwat, N Yongvanit, P Bhudhisawasdi, V Puapairoj, A Riggins, GJ Loilome, W |
2013 | ||||
| 13. | Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model | Hasaya Dokduang Watcharin Loilome Nisana Namwat Anchalee Techasen Chawalit Pairojkul Narong Khuntikeo Yoshinori Murakami Puangrat Yongvanit |
2013 | ||||
| 14. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo A. Dechakhamphu C. Talabnin W. Chan-On C. K. Ong B. T. Teh P. Yongvanit |
2013 | ||||
| 15. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. | Jamnongkan, W. Techasen, A. Thanan, R. Duenngai, K. Sithithaworn, P. Mairiang, E. Loilome, W. Namwat, N. Pairojkul, C. Yongvanit, P. |
2013 | ||||
| 16. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. | Hasaya Dokduang Sirinun Juntana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Gregory J. Riggins Watcharin Loilome |
2013 | ||||
| 17. | The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma | Jurairat Jongthawin Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Chavalit Pairojkul Narong Khuntikeo Nisana Namwat |
2013 | ||||
| 18. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells | Watcharin Loilome Pornpan Bungkanjana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Anucha Puapairoj Narong Khuntikeo Gregory J. Riggins |
2014 | ||||
| 19. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. | Khenjanta, C. Thanan, R. Jusakul, A. Techasen, A. Jamnongkan, W. Namwat, N. Loilome, W. Pairojkul, C. Yongvanit, P. |
2014 | ||||
| 20. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma | Duangkumpha, K Techasen, A Loilome, W Namwat, N Thanan, R Khuntikeo, N Yongvanit, P |
2014 | ||||
| 21. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Porncheera Chusorn Anchalee Techasen Thidarut Boonmars Narong Khuntikeo Nittaya Chamadol Chawalit Pairojkul Nisana Namwat |
2014 | ||||
| 22. | Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression | Yingpinyapat Kittirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 23. | Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 24. | Gene Silencing of Translationally Controlled Tumor Protein (TCTP) | Nattaporn Phanthaphol Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 25. | Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. | Miwa, M Honjo, S You, G Tanaka, M Uchida, K Srivatanakul, P Khuhaprema, T Loilome, W Techasen, A Wongkham, C Limpaiboon, T Yongvanit, P Wongkham, S |
2014 | ||||
| 26. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Suyanee Thongchot Puangrat Yongvanit Watcharin Loilome Wanchana Seubwai Kutcharin Phunicom Wichittra Tassaneeyakul Chawalit Pairojkul Wisuttiphong Promkotra Anchalee Techasen Nisana Namwat |
2014 | ||||
| 27. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Khansaard, W Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Loilome, W |
2014 | ||||
| 28. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. | Techasen, A. Loilome, W. Namwat, N. Khuntikeo, N. Puapairoj, A. Jearanaikoon, P. Saya, H. Yongvanit, P. |
2014 | ||||
| 29. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jongthawin, J Chusorn, P Techasen, A Loilome, W Boonmars, T Thanan, R Puapairoj, A Khuntikeo, N Tassaneeyakul, W Yongvanit, P Namwat, N |
2014 | ||||
| 30. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. | Hasaya Dokduang Anchalee Techasen Nisana Namwat Narong Khuntikeo Chawalit Pairojkul Yoshinori Murakami Watcharin Loilome Puangrat Yongvanit |
2014 | ||||
| 31. | Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment | W. Loilome H. Dokduang S. Yothaisong P. Bungkanjana S. Juntana A. Techasen N. Namwat P. Yongvanit N. Khuntikeo A. Puapairoj |
2014 | ||||
| 32. | TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo B. Tean Teh I. Lee P. Yongvanit |
2014 | ||||
| 33. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. | Techasen, A. Namwat, N. Loilome, W. Duangkumpha, K. Puapairoj, A. Saya, H. Yongvanit, P. |
2014 | ||||
| 34. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. | Chanika Worasith Christine Kamamia Anna Yakovleva Kunyarat Duenngai Chompunoot Wangboon Jiraporn Sithithaworn Nattaya Watwiengkam Nisana Namwat Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Alex Loukas Paiboon Sithithaworn Jeffrey M. Bethony |
2015 | ||||
| 35. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells | Thongchot, S Loilome, W Yongvanit, P Dokduang, H Thanan, R Techasen, A Namwat, N |
2015 | ||||
| 36. | Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis | Thanan, R. Techasen, A. Hou, B. Jamnongkan, W. Armartmuntree, N. Yongvanit, P. |
2015 | ||||
| 37. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wattanawongdon, W Hahnvajanawong, C Namwat, N Kanchanawat, S Boonmars, T Jearanaikoon, P Leelayuwat, C Techasen, A Seubwai, W |
2015 | ||||
| 38. | Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis | Thanee, M Loilome, W Techasen, A Namwat, N Boonmars, T Pairojkul, C Yongvanit, P |
2015 | ||||
| 39. | Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. | Nichapavee Nutthasirikul Chariya Hahnvajanawong Anchalee Techasen Temduang Limpaiboon Chanvit Leelayuwat Siri Chau-In Patcharee Jearanaikoon |
2015 | ||||
| 40. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Eiji Sugihara Shogo Okazaki Shinya Abe Shiho Ueda Takashi Masuko Nisana Namwat Narong Khuntikeo Attapol Titapun Chawalit Pairojkul Hideyuki Saya Puangrat Yongvanit |
2016 | ||||
| 41. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 | ||||
| 42. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. | Xurui Dai Suyanee Thongchot Hasaya Dokduang Watcharin Loilome Narong Khuntikeo Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Anchalee Techasen Nisana Namwat |
2016 | ||||
| 43. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma | Loilome, W. Yongvanit, P. Namwat, N. Techasen, A. Khuntikeo, N. |
2017 | ||||
| 44. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 | ||||
| 45. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem | Hughes, T O'Connor, T Techasen, A Namwat, N Loilome, W Andrews, RH Khuntikeo, N Yongvanit, P Sithithaworn, P Taylor-Robinson, SD |
2017 | ||||
| 46. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. | Armartmuntree, N Murata, M Techasen, A Yongvanit, P Loilome, W Namwat, N Pairojkul, C Sakonsinsiri, C Pinlaor, S Thanan, R |
2017 | ||||
| 47. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 | ||||
| 48. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 | ||||
| 49. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool | Jamnongkan, W Thanan, R Techasen, A Namwat, N Loilome, W Intarawichian, P Titapun, A Yongvanit, P |
2017 | ||||
| 50. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 | ||||
| 51. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Suyanee Thongchot Paiboon Sithithaworn Thidarut Boonmars Supinda Koonmee Attapol Titapun Narong Khuntikeo Nittaya Chamadol Anchalee Techasen Nisana Namwat |
2017 | ||||
| 52. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 | ||||
| 53. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 | ||||
| 54. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. | Chatanun Eamudomkarn Paiboon Sithithaworn Christine Kamamia Anna Yakovleva Jiraporn Sithithaworn Sasithorn Kaewkes Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Chompunoot Wangboon Prasert Saichua Makoto Itoh Jeffrey M. Bethony |
2018 | ||||
| 55. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 | ||||
| 56. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. | Wangboon, C Worasith, C Thanan, R Eamudomkarn, C Techasen, A Sithithaworn, J Loilome, W Chamadol, N Pinlaor, S Jumnainsong, A Yongvanit, P Khuntikeo, N Bethony, JM Sithithaworn, P |
2018 | ||||
| 57. | Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development | Sasikamon Korphai Anchalee Techasen Nisana Namwat Watcharin Loilome |
2018 | ||||
| 58. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 | ||||
| 59. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 | ||||
| 60. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 | ||||
| 61. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 | ||||
| 62. | Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 | ||||
| 63. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 64. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Thongchot, S. Loilome, Techasen, A. Ungarreevittaya, P. Khuntikeo, N. Yongvanit, P. |
2018 | ||||
| 65. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 | ||||
| 66. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 | ||||
| 67. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 | ||||
| 68. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 69. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 70. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 | ||||
| 71. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 | ||||
| 72. | ZNF423 expression in relation to oxidative stress-induced CCA progression | Timpika Chaiprasert Napat Armartmuntree Chadamas Sakonsinsiri Somchai Pinlaor Anchalee Techasen Raynoo Thanan |
2018 | ||||
| 73. | Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols | Eamudomkarn, C. Techasen, A. Sithithaworn, J. Itoh, M. Sithithaworn, P. |
2019 | ||||
| 74. | Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand | Worasith, C Wangboon, C Duenngai, K Kiatsopit, N Kopolrat, K Techasen, A Sithithaworn, J Khuntikeo, N Loilome, W Namwat, N Yongvanit, P Carlton, EJ Sithithaworn, P |
2019 | ||||
| 75. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. | Kassaporn Duangkumpha Thomas Stoll Jutarop Phetcharaburanin Puangrat Yongvanit Raynoo Thanan Anchalee Techasen Nisana Namwat Narong Khuntikeo Nittaya Chamadol Sittiruk Roytrakul Jason Mulvenna Ahmed Mohamed Alok K. Shah Michelle M. Hill Watcharin Loilome |
2019 | ||||
| 76. | Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma | Jamnongkan, W. Techasen, A. Loilome, Sithithaworn, P. Khuntikeo, N. Pairojkul, C. Chamadol, N. Thanan, R. Yongvanit, P. |
2019 | ||||
| 77. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines | Promraksa, B Phetcharaburanin, J Namwat, N Techasen, A Boonsiri, P Loilome, W |
2019 | ||||
| 78. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Chompunoot Wangboon Chanika Worasith Raynoo Thanan Chatanun Eamudomkarn Anchalee Techasen Jiraporn Sithithaworn Watcharin Loilome Nittaya Chamadol Somchai Pinlaor Amonrat Jumnainsong Puangrat Yongvanit Narong Khuntikeo Jeffrey M. Bethony Paiboon Sithithaworn |
2019 | ||||
| 79. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 | ||||
| 80. | Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress | Armartmuntree, N. Techasen, A. Sakonsinsiri, C. Pinlaor, S. Ungarreevittaya, P. Khuntikeo, N. Thanan, R. |
2019 | ||||
| 81. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 | ||||
| 82. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Taron, W Jamnongkan, W Techasen, A Phetcharaburanin, J Namwat, N Sithithaworn, P Khuntikeo, N Mukdasai, S Sayasone, S Loilome, W Ngeontae, W |
2020 | ||||
| 83. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. | Kimawaha, P Jusakul, A Junsawang, P Loilome, W Khuntikeo, N Techasen, A |
2020 | ||||
| 84. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 | ||||
| 85. | Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression | Raynoo Thanan Waleeporn Kaewlert Chadamas Sakonsinsiri Timpika Chaiprasert Napat Armartmuntree Duangkamon Muengsaen Anchalee Techasen Poramate Klanrit Worachart Lert-itthiporn Somchai Pinlaor Chawalit Pairojkul |
2020 | Count | 60 | 59 | 69 | 4 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | รวม | ||||||
| 1. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway | Techasen, A. Loilome, W. Namwat, N. Takahashi, E. Puapairoj, A. Miwa, M. Saya, H. Yongvanit, P. |
2010 |
Cancer Science 3 (101), pp. 658-665 |
||||||||
| 2. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | Namwat, N. Puetkasichonpasutha, J. Loilome, W. Yongvanit, P. Techasen, A. Puapairoj, A. Sripa, B. Tassaneeyakul, W. Khuntikeo, N. Wongkham, S. |
2011 |
Journal of Gastroenterology 5 (46), pp. 664-675 |
||||||||
| 3. | Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines | Jongthawin, J. Techasen, A. Loilome, W. Yongvanit, P. Namwat, N. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 47-51 |
||||||||
| 4. | Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells | Techasen, A. Loilome, W. Namwat, N. Dokduang, H. Jongthawin, J. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 115-118 |
||||||||
| 5. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma | Namwat, N. Chusorn, P. Loilome, W. Techasen, A. Puetkasichonpasutha, J. Pairojkul, C. Khuntikeo, N. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 65-69 |
||||||||
| 6. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development | Loilome, W. Namwat, N. Techasen, A. Puapairoj, A. Pinitsoontorn, C. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 59-64 |
||||||||
| 7. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Yongvanit, P. Thanan, R. Pinlaor, S. Sithithaworn, P. Loilome, W. Namwat, N. Techasen, A. Dechakhamphu, S. |
2012 |
Parasitology Research 5 (110), pp. 1969-1977 |
||||||||
| 8. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis | Techasen, A. Loilome, W. Namwat, N. Duenngai, K. Cha'on, U. Thanan, R. Sithithaworn, P. Miwa, M. Yongvanit, P. |
2012 |
Parasitology International 1 (61), pp. 140-144 |
||||||||
| 9. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | Techasen, A. Namwat, N. Loilome, W. Bungkanjana, P. Khuntikeo, N. Puapairoj, A. Jearanaikoon, P. Saya, H. Yongvanit, P. |
2012 |
Medical Oncology 5 (29), pp. 3083-3091 |
||||||||
| 10. | Annexin A1: A new immunohistological marker of cholangiocarcinoma | Hongsrichan, N. Rucksaken, R. Chamgramol, Y. Pinlaor, P. Techasen, A. Yongvanit, P. Khuntikeo, N. Pairojkul, C. Pinlaor, S. |
2013 |
World Journal of Gastroenterology 16 (19), pp. 2456-2465 |
||||||||
| 11. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Jusakul, A. Loilome, W. Namwat, N. Techasen, A. Ioannou, G.N. Yongvanit, P. |
2013 |
Journal of Steroid Biochemistry and Molecular Biology (138), pp. 368-375 |
||||||||
| 12. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Yothaisong, S. Dokduang, H. Techasen, A. Namwat, N. Yongvanit, P. Bhudhisawasdi, V. Puapairoj, A. Loilome, W. |
2013 |
Tumor Biology 6 (34), pp. 3637-3648 |
||||||||
| 13. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | Chusorn, P. Namwat, N. Loilome, W. Techasen, A. Pairojkul, C. Khuntikeo, N. Talabnin, C. Chan-On, W. Yongvanit, P. |
2013 |
Tumor Biology 3 (34), pp. 1579-1588 |
||||||||
| 14. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma | Jamnongkan, W. Techasen, A. Thanan, R. Duenngai, K. Sithithaworn, P. Mairiang, E. Loilome, W. Namwat, N. Pairojkul, C. Yongvanit, P. |
2013 |
Tumor Biology 2 (34), pp. 695-704 |
||||||||
| 15. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment | Dokduang, H. Juntana, S. Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Loilome, W. |
2013 |
Tumor Biology 6 (34), pp. 3519-3528 |
||||||||
| 16. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells | Loilome, W. Bungkanjana, P. Techasen, A. Namwat, N. Yongvanit, P. Puapairoj, A. Khuntikeo, N. |
2014 |
Tumor Biology 6 (35), pp. 5357-5367 |
||||||||
| 17. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression | Khenjanta, C. Thanan, R. Jusakul, A. Techasen, A. Jamnongkan, W. Namwat, N. Loilome, W. Pairojkul, C. Yongvanit, P. |
2014 |
Asian Pacific Journal of Cancer Prevention 23 (15), pp. 10187-10192 |
||||||||
| 18. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma | Duangkumpha, K. Techasen, A. Loilome, W. Namwat, N. Thanan, R. Khuntikeo, N. Yongvanit, P. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 9667-9676 |
||||||||
| 19. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator | Loilome, W. Yongvanit, P. Chusorn, P. Techasen, A. Boonmars, T. Khuntikeo, N. Chamadol, N. Pairojkul, C. Namwat, N. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 12 (21), pp. 864-872 |
||||||||
| 20. | High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 |
Asian Pacific Journal of Cancer Prevention 14 (15), pp. 5873-5878 |
||||||||
| 21. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Khansaard, W. Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Puapairoj, A. Loilome, W. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 10031-10041 |
||||||||
| 22. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis | Techasen, A. Loilome, W. Namwat, N. Khuntikeo, N. Puapairoj, A. Jearanaikoon, P. Saya, H. Yongvanit, P. |
2014 |
Tumor Biology 9 (35), pp. 8645-8652 |
||||||||
| 23. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jongthawin, J. Chusorn, P. Techasen, A. Loilome, W. Boonmars, T. Thanan, R. Puapairoj, A. Khuntikeo, N. Tassaneeyakul, W. Yongvanit, P. Namwat, N. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-8064 |
||||||||
| 24. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression | Dokduang, H. Techasen, A. Namwat, N. Khuntikeo, N. Pairojkul, C. Murakami, Y. Loilome, W. Yongvanit, P. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 10 (21), pp. 767-776 |
||||||||
| 25. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression | Techasen, A. Namwat, N. Loilome, W. Duangkumpha, K. Puapairoj, A. Saya, H. Yongvanit, P. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 9 (21), pp. 703-711 |
||||||||
| 26. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells | Thongchot, S. Loilome, W. Yongvanit, P. Dokduang, H. Thanan, R. Techasen, A. Namwat, N. |
2015 |
Asian Pacific Journal of Cancer Prevention 5 (16), pp. 2031-2035 |
||||||||
| 27. | Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis | Thanan, R. Techasen, A. Hou, B. Jamnongkan, W. Armartmuntree, N. Yongvanit, P. |
2015 |
Biochemical and Biophysical Research Communications 1 (464), pp. 182-188 |
||||||||
| 28. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wattanawongdon, W. Hahnvajanawong, C. Namwat, N. Kanchanawat, S. Boonmars, T. Jearanaikoon, P. Leelayuwat, C. Techasen, A. Seubwai, W. |
2015 |
International Journal of Oncology 1 (47), pp. 398-410 |
||||||||
| 29. | Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Boonmars, T. Pairojkul, C. Yongvanit, P. |
2015 |
Asian Pacific Journal of Cancer Prevention 7 (16), pp. 3043-3050 |
||||||||
| 30. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science (), pp. |
||||||||
| 31. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science 7 (107), pp. 991-1000 |
||||||||
| 32. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2016 |
Tumor Biology (), pp. 1-9 |
||||||||
| 33. | Potential of selenium compounds as new anticancer agents for cholangiocarcinoma | Thongchot, S. Dokduang, H. Loilome, W. Khuntikeo, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. Techasen, A. Namwat, N. |
2016 |
Anticancer Research 11 (36), pp. 5981-5988 |
||||||||
| 34. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma | Loilome, W. Yongvanit, P. Namwat, N. Techasen, A. Khuntikeo, N. |
2017 |
Oncology Letters 2 (13), pp. 639-646 |
||||||||
| 35. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Thanee, M. Techasen, A. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Anticancer Research 7 (37), pp. 3591-3597 |
||||||||
| 36. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem | Techasen, A. Loilome, W. Khuntikeo, N. Yongvanit, P. Sithithaworn, P. |
2017 |
International Journal of General Medicine (10), pp. 227-237 |
||||||||
| 37. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Titapun, A. Koonmee, S. Loilome, W. |
2017 |
Parasitology International 4 (66), pp. 486-493 |
||||||||
| 38. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Techasen, A. Thongchot, S. Thanan, R. Khuntikeo, N. Yongvanit, P. |
2017 |
Oncology Letters 5 (14), pp. 5973-5979 |
||||||||
| 39. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool | Jamnongkan, W. Thanan, R. Techasen, A. Namwat, N. Loilome, W. Intarawichian, P. Titapun, A. Yongvanit, P. |
2017 |
Tumor Biology 7 (39), pp. 1-10 |
||||||||
| 40. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Loilome, W. Yongvanit, P. Thongchot, S. Namwat, N. Sithithaworn, P. Boonmars, T. Koonmee, S. Titapun, A. Khuntikeo, N. Chamadol, N. Techasen, A. |
2017 |
Parasitology International 4 (66), pp. 479-485 |
||||||||
| 41. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 |
PeerJ 1 (2018), pp. |
||||||||
| 42. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis | Eamudomkarn, C. Sithithaworn, P. Sithithaworn, J. Kaewkes, S. Techasen, A. Loilome, Yongvanit, P. Saichua, P. Itoh, M. |
2018 |
PLoS ONE 7 (13), pp. |
||||||||
| 43. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 |
FEBS Open Bio 4 (8), pp. 513-522 |
||||||||
| 44. | Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 |
Oncology Letters 2 (16), pp. 1627-1633 |
||||||||
| 45. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Thongchot, S. Loilome, Techasen, A. Ungarreevittaya, P. Khuntikeo, N. Yongvanit, P. |
2018 |
PLoS ONE 6 (13), pp. |
||||||||
| 46. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Loilome, W. Techasen, A. Thanee, M. Titapun, A. Yongvanit, P. Namwat, N. |
2018 |
OncoTargets and Therapy (11), pp. 395-408 |
||||||||
| 47. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Armartmuntree, N. Techasen, A. Yongvanit, P. Loilome, W. Pairojkul, C. Sakonsinsiri, C. Pinlaor, S. Thanan, R. |
2018 |
Redox Biology (14), pp. 637-644 |
||||||||
| 48. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 |
Oncology Letters 1 (15), pp. 347-353 |
||||||||
| 49. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 50. | Accuracy of urine and serum assays for the diagnosis of strongyloidiasis by three enzyme-linked immunosorbent assay protocols | Eamudomkarn, C. Techasen, A. Sithithaworn, J. Itoh, M. Sithithaworn, P. |
2019 |
American Journal of Tropical Medicine and Hygiene 1 (100), pp. 127-129 |
||||||||
| 51. | Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand | Duenngai, K. Kiatsopit, N. Kopolrat, K. Techasen, A. Sithithaworn, J. Khuntikeo, N. Loilome, Yongvanit, P. Sithithaworn, P. |
2019 |
PLoS Neglected Tropical Diseases 2 (13), pp. |
||||||||
| 52. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis | Duangkumpha, K. Phetcharaburanin, J. Yongvanit, P. Thanan, R. Techasen, A. Khuntikeo, N. Chamadol, N. Mulvenna, J.P. Loilome, |
2019 |
Journal of Proteome Research 9 (18), pp. 3305-3316 |
||||||||
| 53. | Discovery of serotransferrin glycoforms: Novel markers for diagnosis of liver periductal fibrosis and prediction of cholangiocarcinoma | Jamnongkan, W. Techasen, A. Loilome, Sithithaworn, P. Khuntikeo, N. Pairojkul, C. Chamadol, N. Thanan, R. Yongvanit, P. |
2019 |
Biomolecules 10 (9), pp. |
||||||||
| 54. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines | Promraksa, B. Phetcharaburanin, J. Techasen, A. Boonsiri, P. Loilome, |
2019 |
PLoS ONE 5 (14), pp. |
||||||||
| 55. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Thanan, R. Eamudomkarn, C. Techasen, A. Sithithaworn, J. Loilome, Chamadol, N. Pinlaor, S. Jumnainsong, A. Yongvanit, P. Khuntikeo, N. Sithithaworn, P. |
2019 |
Acta Tropica (189), pp. 124-128 |
||||||||
| 56. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 57. | Roles of zinc finger protein 423 in proliferation and invasion of cholangiocarcinoma through oxidative stress | Armartmuntree, N. Techasen, A. Sakonsinsiri, C. Pinlaor, S. Ungarreevittaya, P. Khuntikeo, N. Thanan, R. |
2019 |
Biomolecules 7 (9), pp. |
||||||||
| 58. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Duangkumpha, K. Phetcharaburanin, J. Yongvanit, P. Thanan, R. Techasen, A. Khuntikeo, N. Chamadol, N. Mulvenna, J.P. Loilome, |
2019 |
PLoS ONE 8 (14), pp. |
||||||||
| 59. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Sithithaworn, P. Khuntikeo, N. Mukdasai, S. Sayasone, S. Loilome, W. Ngeontae, W. |
2020 |
Talanta (209), pp. |
||||||||
| 60. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 |
Journal of Traditional and Complementary Medicine (), pp. |
||||||||
| 61. | Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression | Thanan, R. Sakonsinsiri, C. Armartmuntree, N. Techasen, A. Klanrit, P. Lert-Itthiporn, W. Pinlaor, S. Pairojkul, C. |
2020 |
International Journal of Molecular Sciences 5 (21), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. | Techasen, A Loilome, W Namwat, N Takahashi, E Sugihara, E Puapairoj, A Miwa, M Saya, H Yongvanit, P |
2010 |
Cancer science 3 (101), pp. 658-65 |
|
| 2. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | Namwat, N Puetkasichonpasutha, J Loilome, W Yongvanit, P Techasen, A Puapairoj, A Sripa, B Tassaneeyakul, W Khuntikeo, N Wongkham, S |
2011 |
Journal of gastroenterology 5 (46), pp. 664-75 |
|
| 3. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. | Techasen, A Namwat, N Loilome, W Bungkanjana, P Khuntikeo, N Puapairoj, A Jearanaikoon, P Saya, H Yongvanit, P |
2012 |
Medical oncology (Northwood, London, England) 5 (29), pp. 3083-91 |
|
| 4. | Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. | Jongthawin, J Techasen, A Loilome, W Yongvanit, P Namwat, N |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 47-51 |
|
| 5. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. | Loilome, W Kadsanit, S Namwat, N Techasen, A Puapairoj, A Dechakhamphu, A Pinitsoontorn, C Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 59-64 |
|
| 6. | Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. | Techasen, A Loilome, W Namwat, N Dokduang, H Jongthawin, J Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 115-8 |
|
| 7. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. | Namwat, N Chusorn, P Loilome, W Techasen, A Puetkasichonpasutha, J Pairojkul, C Khuntikeo, N Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 65-9 |
|
| 8. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. | Techasen, A Loilome, W Namwat, N Duenngai, K Cha'on, U Thanan, R Sithithaworn, P Miwa, M Yongvanit, P |
2012 |
Parasitology international 1 (61), pp. 140-4 |
|
| 9. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. | Yongvanit, P Thanan, R Pinlaor, S Sithithaworn, P Loilome, W Namwat, N Techasen, A Dechakhamphu, S |
2012 |
Parasitology research 5 (110), pp. 1969-77 |
|
| 10. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. | Jusakul, A Loilome, W Namwat, N Techasen, A Kuver, R Ioannou, GN Savard, C Haigh, WG Yongvanit, P |
2013 |
The Journal of steroid biochemistry and molecular biology (138), pp. 368-75 |
|
| 11. | Annexin A1: A new immunohistological marker of cholangiocarcinoma. | Hongsrichan, N Rucksaken, R Chamgramol, Y Pinlaor, P Techasen, A Yongvanit, P Khuntikeo, N Pairojkul, C Pinlaor, S |
2013 |
World journal of gastroenterology : WJG 16 (19), pp. 2456-65 |
|
| 12. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. | Yothaisong, S Dokduang, H Techasen, A Namwat, N Yongvanit, P Bhudhisawasdi, V Puapairoj, A Riggins, GJ Loilome, W |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (34), pp. 3637-48 |
|
| 13. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. | Chusorn, P Namwat, N Loilome, W Techasen, A Pairojkul, C Khuntikeo, N Dechakhamphu, A Talabnin, C Chan-On, W Ong, CK Teh, BT Yongvanit, P |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (34), pp. 1579-88 |
|
| 14. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. | Jamnongkan, W Techasen, A Thanan, R Duenngai, K Sithithaworn, P Mairiang, E Loilome, W Namwat, N Pairojkul, C Yongvanit, P |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2 (34), pp. 695-704 |
|
| 15. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. | Dokduang, H Juntana, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Riggins, GJ Loilome, W |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (34), pp. 3519-28 |
|
| 16. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. | Jongthawin, J Chusorn, P Techasen, A Loilome, W Boonmars, T Thanan, R Puapairoj, A Khuntikeo, N Tassaneeyakul, W Yongvanit, P Namwat, N |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-64 |
|
| 17. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Thongchot, S Yongvanit, P Loilome, W Seubwai, W Phunicom, K Tassaneeyakul, W Pairojkul, C Promkotra, W Techasen, A Namwat, N |
2014 |
Asian Pacific journal of cancer prevention : APJCP 14 (15), pp. 5873-8 |
|
| 18. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. | Techasen, A Loilome, W Namwat, N Khuntikeo, N Puapairoj, A Jearanaikoon, P Saya, H Yongvanit, P |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 9 (35), pp. 8645-52 |
|
| 19. | Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. | Miwa, M Honjo, S You, G Tanaka, M Uchida, K Srivatanakul, P Khuhaprema, T Loilome, W Techasen, A Wongkham, C Limpaiboon, T Yongvanit, P Wongkham, S |
2014 |
World journal of gastrointestinal pathophysiology 4 (5), pp. 570-8 |
|
| 20. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. | Khenjanta, C Thanan, R Jusakul, A Techasen, A Jamnongkan, W Namwat, N Loilome, W Pairojkul, C Yongvanit, P |
2014 |
Asian Pacific journal of cancer prevention : APJCP 23 (15), pp. 10187-92 |
|
| 21. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. | Silakit, R Loilome, W Yongvanit, P Chusorn, P Techasen, A Boonmars, T Khuntikeo, N Chamadol, N Pairojkul, C Namwat, N |
2014 |
Journal of hepato-biliary-pancreatic sciences 12 (21), pp. 864-72 |
|
| 22. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. | Dokduang, H Techasen, A Namwat, N Khuntikeo, N Pairojkul, C Murakami, Y Loilome, W Yongvanit, P |
2014 |
Journal of hepato-biliary-pancreatic sciences 10 (21), pp. 767-76 |
|
| 23. | Increased EphB2 expression predicts cholangiocarcinoma metastasis. | Khansaard, W Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Loilome, W |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 10031-41 |
|
| 24. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. | Duangkumpha, K Techasen, A Loilome, W Namwat, N Thanan, R Khuntikeo, N Yongvanit, P |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 9667-76 |
|
| 25. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. | Techasen, A Namwat, N Loilome, W Duangkumpha, K Puapairoj, A Saya, H Yongvanit, P |
2014 |
Journal of hepato-biliary-pancreatic sciences 9 (21), pp. 703-11 |
|
| 26. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. | Loilome, W Bungkanjana, P Techasen, A Namwat, N Yongvanit, P Puapairoj, A Khuntikeo, N Riggins, GJ |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (35), pp. 5357-67 |
|
| 27. | Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. | Thanee, M Loilome, W Techasen, A Namwat, N Boonmars, T Pairojkul, C Yongvanit, P |
2015 |
Asian Pacific journal of cancer prevention : APJCP 7 (16), pp. 3043-50 |
|
| 28. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. | Thongchot, S Loilome, W Yongvanit, P Dokduang, H Thanan, R Techasen, A Namwat, N |
2015 |
Asian Pacific journal of cancer prevention : APJCP 5 (16), pp. 2031-5 |
|
| 29. | Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. | Nutthasirikul, N Hahnvajanawong, C Techasen, A Limpaiboon, T Leelayuwat, C Chau-In, S Jearanaikoon, P |
2015 |
International journal of oncology (), pp. |
|
| 30. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. | Worasith, C Kamamia, C Yakovleva, A Duenngai, K Wangboon, C Sithithaworn, J Watwiengkam, N Namwat, N Techasen, A Loilome, W Yongvanit, P Loukas, A Sithithaworn, P Bethony, JM |
2015 |
PLoS neglected tropical diseases 10 (9), pp. e0004157 |
|
| 31. | Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis. | Thanan, R Techasen, A Hou, B Jamnongkan, W Armartmuntree, N Yongvanit, P Murata, M |
2015 |
Biochemical and biophysical research communications 1 (464), pp. 182-8 |
|
| 32. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. | Wattanawongdon, W Hahnvajanawong, C Namwat, N Kanchanawat, S Boonmars, T Jearanaikoon, P Leelayuwat, C Techasen, A Seubwai, W |
2015 |
International journal of oncology 1 (47), pp. 398-410 |
|
| 33. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (37), pp. 13659-13667 |
|
| 34. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | Thanee, M Loilome, W Techasen, A Sugihara, E Okazaki, S Abe, S Ueda, S Masuko, T Namwat, N Khuntikeo, N Titapun, A Pairojkul, C Saya, H Yongvanit, P |
2016 |
Cancer science 7 (107), pp. 991-1000 |
|
| 35. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. | Dai, X Thongchot, S Dokduang, H Loilome, W Khuntikeo, N Titapun, A Ungarreevittaya, P Yongvanit, P Techasen, A Namwat, N |
2016 |
Anticancer research 11 (36), pp. 5981-5988 |
|
| 36. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. | Silakit, R Loilome, W Yongvanit, P Thongchot, S Sithithaworn, P Boonmars, T Koonmee, S Titapun, A Khuntikeo, N Chamadol, N Techasen, A Namwat, N |
2017 |
Parasitology international 4 (66), pp. 479-485 |
|
| 37. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Suksawat, M Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Koonmee, S Loilome, W |
2017 |
Parasitology international 4 (66), pp. 486-493 |
|
| 38. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. | Loilome, W Kadsanit, S Muisook, K Yongvanit, P Namwat, N Techasen, A Puapairoj, A Khuntikeo, N Phonjit, P |
2017 |
Oncology letters 2 (13), pp. 639-646 |
|
| 39. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Padthaisong, S Thanee, M Techasen, A Namwat, N Yongvanit, P Liwatthakun, A Hankla, K Sangkhamanon, S Loilome, W |
2017 |
Anticancer research 7 (37), pp. 3591-3597 |
|
| 40. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. | Jamnongkan, W Thanan, R Techasen, A Namwat, N Loilome, W Intarawichian, P Titapun, A Yongvanit, P |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (39), pp. 1010428317717655 |
|
| 41. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. | Hughes, T O'Connor, T Techasen, A Namwat, N Loilome, W Andrews, RH Khuntikeo, N Yongvanit, P Sithithaworn, P Taylor-Robinson, SD |
2017 |
International journal of general medicine (10), pp. 227-237 |
|
| 42. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. | Armartmuntree, N Murata, M Techasen, A Yongvanit, P Loilome, W Namwat, N Pairojkul, C Sakonsinsiri, C Pinlaor, S Thanan, R |
2017 |
Redox biology (14), pp. 637-644 |
|
| 43. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
| 44. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. | Jamnongkan, W Thanee, M Yongvanit, P Loilome, W Thanan, R Kimawaha, P Boonmars, T Silakit, R Namwat, N Techasen, A |
2018 |
PeerJ (6), pp. e4281 |
|
| 45. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 46. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Daya, M Loilome, W Techasen, A Thanee, M Sa-Ngiamwibool, P Titapun, A Yongvanit, P Namwat, N |
2018 |
OncoTargets and therapy (11), pp. 395-408 |
|
| 47. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 |
FEBS open bio 4 (8), pp. 513-522 |
|
| 48. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. | Silakit, R Kitirat, Y Thongchot, S Loilome, W Techasen, A Ungarreevittaya, P Khuntikeo, N Yongvanit, P Yang, JH Kim, NH Yook, JI Namwat, N |
2018 |
PloS one 6 (13), pp. e0199827 |
|
| 49. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. | Eamudomkarn, C Sithithaworn, P Kamamia, C Yakovleva, A Sithithaworn, J Kaewkes, S Techasen, A Loilome, W Yongvanit, P Wangboon, C Saichua, P Itoh, M M Bethony, J |
2018 |
PloS one 7 (13), pp. e0192598 |
|
| 50. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 |
Oncology letters 2 (16), pp. 1627-1633 |
|
| 51. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. | Wangboon, C Worasith, C Thanan, R Eamudomkarn, C Techasen, A Sithithaworn, J Loilome, W Chamadol, N Pinlaor, S Jumnainsong, A Yongvanit, P Khuntikeo, N Bethony, JM Sithithaworn, P |
2018 |
Acta tropica (189), pp. 124-128 |
|
| 52. | Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols. | Ruantip, S Eamudomkarn, C Techasen, A Wangboon, C Sithithaworn, J Bethony, JM Itoh, M Sithithaworn, P |
2019 |
The American journal of tropical medicine and hygiene 1 (100), pp. 127-129 |
|
| 53. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. | Promraksa, B Phetcharaburanin, J Namwat, N Techasen, A Boonsiri, P Loilome, W |
2019 |
PloS one 5 (14), pp. e0216721 |
|
| 54. | Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. | Worasith, C Wangboon, C Duenngai, K Kiatsopit, N Kopolrat, K Techasen, A Sithithaworn, J Khuntikeo, N Loilome, W Namwat, N Yongvanit, P Carlton, EJ Sithithaworn, P |
2019 |
PLoS neglected tropical diseases 2 (13), pp. e0007186 |
|
| 55. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
| 56. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 |
Journal of proteome research 9 (18), pp. 3305-3316 |
|
| 57. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 |
PloS one 8 (14), pp. e0221024 |
|
| 58. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. | Taron, W Jamnongkan, W Techasen, A Phetcharaburanin, J Namwat, N Sithithaworn, P Khuntikeo, N Mukdasai, S Sayasone, S Loilome, W Ngeontae, W |
2020 |
Talanta (209), pp. 120592 |
|
| 59. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. | Kimawaha, P Jusakul, A Junsawang, P Loilome, W Khuntikeo, N Techasen, A |
2020 |
Journal of gastrointestinal oncology 2 (11), pp. 304-318 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | รวม | ||||||
| 1. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway | Anchalee Techasen Watcharin Loilome Nisana Namwat Eri Takahashi Eiji Sugihara Anucha Puapairoj Masanao Miwa Hideyuki Saya Puangrat Yongvanit |
2010 |
CANCER SCIENCE 3.0 (101.0), pp. 658.0-665.0 |
74 | 0 | 0 | 0 | 0 | 0 | 74 | |
| 2. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | N. Namwat J. Puetkasichonpasutha W. Loilome P. Yongvanit A. Techasen A. Puapairoj B. Sripa W. Tassaneeyakul N. Khuntikeo S. Wongkham |
2011 |
JOURNAL OF GASTROENTEROLOGY 5.0 (46.0), pp. 664.0-675.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 3. | Anti-inflammatory Agents Suppress the Prostaglandin E-2 Production and Migration Ability of Cholangiocarcinoma Cell Lines | Jurairat Jongthawin Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Nisana Namwat |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 47.0-51.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 4. | Cytokines Released from Activated Human Macrophages Induce Epithelial Mesenchymal Transition Markers of Cholangiocarcinoma Cells | Anchalee Techasen Watcharin Loilome Nisana Namwat Hasaya Dokduang Jurairat Jongthawin Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 115.0-118.0 |
51 | 0 | 0 | 0 | 0 | 0 | 51 | |
| 5. | Expression Profiles of Oncomir miR-21 and Tumor Suppressor let-7a in the Progression of Opisthorchiasis-Associated Cholangiocarcinoma | N. Namwat P. Chusorn W. Loilome A. Techasen J. Puetkasichonpasutha C. Pairojkul N. Khuntikeo P. Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 65.0-69.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 6. | Impaired Antioxidant Enzyme Activity and Increased DNA Repair Enzyme Expression in Hamster Liver Tissues Related to Cholangiocarcinoma Development | Watcharin Loilome Sasithorn Kadsanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Ananya Dechakhamphu Chadamas Pinitsoontorn Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 59.0-64.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 7. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Puangrat Yongvanit Raynoo Thanan Somchai Pinlaor Paiboon Sithithaworn Watcharin Loilome Nisana Namwat Anchalee Techasen Somkid Dechakhamphu |
2012 |
PARASITOLOGY RESEARCH 5.0 (110.0), pp. 1969.0-1977.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 8. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis | Anchalee Techasen Watcharin Loilome Nisana Namwat Kunyarat Duenngai Ubon Cha'on Raynoo Thanan Paiboon Sithithaworn Masanao Miwa Puangrat Yongvanit |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 140.0-144.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 9. | Tumor Necrosis Factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | A. Techasen N. Namwat W. Loilome |
2012 |
FEBS JOURNAL (279.0), pp. 169.0-170.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 10. | Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | Anchalee Techasen Nisana Namwat Watcharin Loilome Pornpan Bungkanjana Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2012 |
MEDICAL ONCOLOGY 5.0 (29.0), pp. 3083.0-3091.0 |
74 | 0 | 0 | 0 | 0 | 0 | 74 | |
| 11. | Annexin A1: A new immunohistological marker of cholangiocarcinoma | Nuttanan Hongsrichan Rucksak Rucksaken Yaovalux Chamgramol Porntip Pinlaor Anchalee Techasen Puangrat Yongvanit Narong Khuntikeo Chawalit Pairojkul Somchai Pinlaor |
2013 |
WORLD JOURNAL OF GASTROENTEROLOGY 16.0 (19.0), pp. 2456.0-2465.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 12. | Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Apinya Jusakul Watcharin Loilome Nisana Namwat Anchalee Techasen Rahul Kuver George N. Ioannou Christopher Savard W. Geoffrey Haigh Puangrat Yongvanit |
2013 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (138.0), pp. 368.0-375.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 13. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Supak Yothaisong Hasaya Dokduang Anchalee Techasen Nisana Namwat Puangrat Yongvanit Vajarabhongsa Bhudhisawasdi Anucha Puapairoj Gregory J. Riggins Watcharin Loilome |
2013 |
TUMOR BIOLOGY 6.0 (34.0), pp. 3637.0-3648.0 |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 14. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo A. Dechakhamphu C. Talabnin W. Chan-On C. K. Ong B. T. Teh P. Yongvanit |
2013 |
TUMOR BIOLOGY 3.0 (34.0), pp. 1579.0-1588.0 |
65 | 0 | 0 | 0 | 0 | 0 | 65 | |
| 15. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma | Wassana Jamnongkan Anchalee Techasen Raynoo Thanan Kunyarat Duenngai Paiboon Sithithaworn Eimorn Mairiang Watcharin Loilome Nisana Namwat Chawalit Pairojkul Puangrat Yongvanit |
2013 |
TUMOR BIOLOGY 2.0 (34.0), pp. 695.0-704.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 16. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment | Hasaya Dokduang Sirinun Juntana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Gregory J. Riggins Watcharin Loilome |
2013 |
TUMOR BIOLOGY 6.0 (34.0), pp. 3519.0-3528.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 17. | The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma | Jurairat Jongthawin Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Chavalit Pairojkul Narong Khuntikeo Nisana Namwat |
2013 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (28.0), pp. 425.0-425.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 18. | Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells | Watcharin Loilome Pornpan Bungkanjana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Anucha Puapairoj Narong Khuntikeo Gregory J. Riggins |
2014 |
TUMOR BIOLOGY 6.0 (35.0), pp. 5357.0-5367.0 |
60 | 0 | 0 | 0 | 0 | 0 | 60 | |
| 19. | Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression | Chakkaphan Khenjanta Raynoo Thanan Apinya Jusakul Anchalee Techasen Wassana Jamnongkan Nisana Namwat Watcharin Loilome Chawalit Pairojkul Puangrat Yongvanit |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 23.0 (15.0), pp. 10187.0-10192.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 20. | BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma | Kassaporn Duangkumpha Anchalee Techasen Watcharin Loilome Nisana Namwat Raynoo Thanan Narong Khuntikeo Puangrat Yongvanit |
2014 |
TUMOR BIOLOGY 10.0 (35.0), pp. 9667.0-9676.0 |
49 | 0 | 0 | 0 | 0 | 0 | 49 | |
| 21. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Porncheera Chusorn Anchalee Techasen Thidarut Boonmars Narong Khuntikeo Nittaya Chamadol Chawalit Pairojkul Nisana Namwat |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 12.0 (21.0), pp. 864.0-872.0 |
66 | 0 | 0 | 0 | 0 | 0 | 66 | |
| 22. | High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis | Suyanee Thongchot Puangrat Yongvanit Watcharin Loilome Wanchana Seubwai Kutcharin Phunicom Wichittra Tassaneeyakul Chawalit Pairojkul Wisuttiphong Promkotra Anchalee Techasen Nisana Namwat |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 14.0 (15.0), pp. 5873.0-5878.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 23. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Walaiporn Khansaard Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Anucha Puapairoj Watcharin Loilome |
2014 |
TUMOR BIOLOGY 10.0 (35.0), pp. 10031.0-10041.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 24. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis | Anchalee Techasen Watcharin Loilome Nisana Namwat Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2014 |
TUMOR BIOLOGY 9.0 (35.0), pp. 8645.0-8652.0 |
43 | 0 | 0 | 0 | 0 | 0 | 43 | |
| 25. | PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jurairat Jongthawin Porncheera Chusorn Anchalee Techasen Watcharin Loilome Thidarut Boonmars Raynoo Thanan Anucha Puapairoj Narong Khuntikeo Wichittra Tassaneeyakul Puangrat Yongvanit Nisana Namwat |
2014 |
TUMOR BIOLOGY 8.0 (35.0), pp. 8051.0-8064.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 26. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression | Hasaya Dokduang Anchalee Techasen Nisana Namwat Narong Khuntikeo Chawalit Pairojkul Yoshinori Murakami Watcharin Loilome Puangrat Yongvanit |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 10.0 (21.0), pp. 767.0-776.0 |
52 | 0 | 0 | 0 | 0 | 0 | 52 | |
| 27. | Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment | W. Loilome H. Dokduang S. Yothaisong P. Bungkanjana S. Juntana A. Techasen N. Namwat P. Yongvanit N. Khuntikeo A. Puapairoj |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S210-S210 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 28. | TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo B. Tean Teh I. Lee P. Yongvanit |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S63-S64 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 29. | Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression | Anchalee Techasen Nisana Namwat Watcharin Loilome Kassaporn Duangkumpha Anucha Puapairoj Hideyuki Saya Puangrat Yongvanit |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 9.0 (21.0), pp. 703.0-711.0 |
44 | 0 | 0 | 0 | 0 | 0 | 44 | |
| 30. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine | Chanika Worasith Christine Kamamia Anna Yakovleva Kunyarat Duenngai Chompunoot Wangboon Jiraporn Sithithaworn Nattaya Watwiengkam Nisana Namwat Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Alex Loukas Paiboon Sithithaworn Jeffrey M. Bethony |
2015 |
PLoS Neglected Tropical Diseases 10.0 (9.0), pp. |
35 | 2 | 0 | 0 | 0 | 0 | 37 | |
| 31. | Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis | Raynoo Thanan Anchalee Techasen Bo Hou Wassana Jamnongkan Napat Armartmuntree Puangrat Yongvanit Mariko Murata |
2015 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 1.0 (464.0), pp. 182.0-188.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 32. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wareeporn Wattanawongdon Chariya Hahnvajanawong Nisana Namwat Sirimas Kanchanawat Thidarut Boonmars Patcharee Jearanaikoon Chanwit Leelayuwat Anchalee Techasen Wunchana Seubwai |
2015 |
INTERNATIONAL JOURNAL OF ONCOLOGY 1.0 (47.0), pp. 398.0-410.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 33. | Targeting the Delta 133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells | Nichapavee Nutthasirikul Chariya Hahnvajanawong Anchalee Techasen Temduang Limpaiboon Chanvit Leelayuwat Siri Chau-In Patcharee Jearanaikoon |
2015 |
INTERNATIONAL JOURNAL OF ONCOLOGY 6.0 (47.0), pp. 2153.0-2164.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 34. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Eiji Sugihara Shogo Okazaki Shinya Abe Shiho Ueda Takashi Masuko Nisana Namwat Narong Khuntikeo Attapol Titapun Chawalit Pairojkul Hideyuki Saya Puangrat Yongvanit |
2016 |
CANCER SCIENCE 7.0 (107.0), pp. 991.0-1000.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 35. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Daraporn Chua-on Tanakorn Proungvitaya Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sungkhamanon Siriporn Proungvitaya |
2016 |
TUMOR BIOLOGY 10.0 (37.0), pp. 13659.0-13667.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 36. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Hasaya Dokduang Watcharin Loilome Narong Khuntikeo Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Anchalee Techasen Nisana Namwat |
2016 |
ANTICANCER RESEARCH 11.0 (36.0), pp. 5981.0-5988.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 37. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma | Watcharin Loilome Sasithorn Kadsanit Kanha Muisook Puangrat Yongvanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Narong Khuntikeo Pichai Phonjit |
2017 |
ONCOLOGY LETTERS 2.0 (13.0), pp. 639.0-646.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 38. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 |
ANTICANCER RESEARCH 7.0 (37.0), pp. 3591.0-3597.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 39. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem | Thomas Hughes Thomas O'Connor Anchalee Techasen Nisana Namwat Watcharin Loilome Ross H. Andrews- Narong Khuntikeo Puangrat Yongvanit Paiboon Sithithaworn Simon D. Taylor-Robinson |
2017 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (10.0), pp. 227.0-237.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 40. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 486.0-493.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 41. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 |
ONCOLOGY LETTERS 5.0 (14.0), pp. 5973.0-5979.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 42. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 |
TUMOR BIOLOGY 7.0 (39.0), pp. |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 43. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Suyanee Thongchot Paiboon Sithithaworn Thidarut Boonmars Supinda Koonmee Attapol Titapun Narong Khuntikeo Nittaya Chamadol Anchalee Techasen Nisana Namwat |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 479.0-485.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 44. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Rayno Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat Anchalee Techasen |
2018 |
PEERJ (6.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 45. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 |
CANCER SCIENCE (109.0), pp. 37.0-37.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 46. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis | Chatanun Eamudomkarn Paiboon Sithithaworn Christine Kamamia Anna Yakovleva Jiraporn Sithithaworn Sasithorn Kaewkes Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Chompunoot Wangboon Prasert Saichua Makoto Itoh Jeffrey M. Bethony |
2018 |
PLOS ONE 7.0 (13.0), pp. |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 47. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 |
CANCER SCIENCE (109.0), pp. 721.0-721.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 48. | Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development | Sasikamon Korphai Anchalee Techasen Nisana Namwat Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 194.0-194.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 49. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Manida Suksawat Anchalee Techasen Nisana Namwat Thianrut Boonsong Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Watcharin Loilome |
2018 |
FEBS OPEN BIO 4.0 (8.0), pp. 513.0-522.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 50. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 746.0-746.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 51. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
ONCOLOGY LETTERS 2.0 (16.0), pp. 1627.0-1633.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 52. | Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 |
CANCER SCIENCE (109.0), pp. 1286.0-1286.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 53. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 745.0-745.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 54. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Runglawan Silakit Yingpinyapat Kitirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Piti Ungarreevittaya Narong Khuntikeo Puangrat Yongvanit Ji Hye Yang Nam Hee Kim Jong In Yook Nisana Namwat |
2018 |
PLOS ONE 6.0 (13.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 55. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 395.0-408.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 56. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 |
REDOX BIOLOGY (14.0), pp. 637.0-644.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 57. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 58. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 |
CANCER SCIENCE (109.0), pp. 956.0-956.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 59. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 60. | ZNF423 expression in relation to oxidative stress-induced CCA progression | Timpika Chaiprasert Napat Armartmuntree Chadamas Sakonsinsiri Somchai Pinlaor Anchalee Techasen Raynoo Thanan |
2018 |
CANCER SCIENCE (109.0), pp. 1285.0-1285.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 61. | Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols | Sirowan Ruantip Chatanun Eamudomkarn Anchalee Techasen Chompunoot Wangboon Jiraporn Sithithaworn Jeffrey M. Bethony Makoto Itoh Paiboon Sithithaworn |
2019 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 1.0 (100.0), pp. 127.0-129.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 62. | Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand | Chanika Worasith Chompunoot Wangboon Kunyarat Duenngai Nadda Kiatsopit Kulthida Kopolrat Anchalee Techasen Jiraporn Sithithaworn Narong Khuntikeo Watcharin Loilome Nisana Namwat Puangrat Yongvanit Elizabeth J. Carlton Paiboon Sithithaworn |
2019 |
PLOS NEGLECTED TROPICAL DISEASES 2.0 (13.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 63. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis | Kassaporn Duangkumpha Thomas Stoll Jutarop Phetcharaburanin Puangrat Yongvanit Raynoo Thanan Anchalee Techasen Nisana Namwat Narong Khuntikeo Nittaya Chamadol Sittiruk Roytrakul Jason Mulvenna Ahmed Mohamed Alok K. Shah Michelle M. Hill Watcharin Loilome |
2019 |
JOURNAL OF PROTEOME RESEARCH 9.0 (18.0), pp. 3305.0-3316.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 64. | Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma | Wassana Jamnongkan Carlito B. Lebrilla Mariana Barboza Anchalee Techasen Watcharin Loilome Paiboon Sithithaworn Narong Khuntikeo Chawalit Pairojkul Nittaya Chamadol Raynoo Thanan Puangrat Yongvanit |
2019 |
BIOMOLECULES 10.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 65. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines | Bundit Promraksa Jutarop Phetcharaburanin Nisana Namwat Anchalee Techasen Patcharee Boonsiri Watcharin Loilome |
2019 |
PLOS ONE 5.0 (14.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 66. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Chompunoot Wangboon Chanika Worasith Raynoo Thanan Chatanun Eamudomkarn Anchalee Techasen Jiraporn Sithithaworn Watcharin Loilome Nittaya Chamadol Somchai Pinlaor Amonrat Jumnainsong Puangrat Yongvanit Narong Khuntikeo Jeffrey M. Bethony Paiboon Sithithaworn |
2019 |
ACTA TROPICA (189.0), pp. 124.0-128.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 67. | Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress | Timpika Chaiprasert Napat Armartmuntree Anchalee Techasen Chadamas Sakonsinsiri Somchai Pinlaor Piti Ungarreevittaya Narong Khuntikeo Nisana Namwat Raynoo Thanan |
2019 |
BIOMOLECULES 7.0 (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 68. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Kassaporn Duangkumpha Thomas Stoll Jutarop Phetcharaburanin Puangrat Yongvanit Raynoo Thanan Anchalee Techasen Nisana Namwat Narong Khuntikeo Nittaya Chamadol Sittiruk Roytrakul Jason Mulvenna Ahmed Mohamed Alok K. Shah Michelle M. Hill Watcharin Loilome |
2019 |
PLOS ONE 8.0 (14.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 69. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Wichit Taron Wassana Jamnongkan Anchalee Techasen Jutarop Phetcharaburanin Nisana Namwat Paiboon Sithithaworn Narong Khuntikeo Siriboon Mukdasai Somphou Sayasone Watcharin Loilome Wittaya Ngeontae |
2020 |
TALANTA (209.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 70. | Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression | Raynoo Thanan Waleeporn Kaewlert Chadamas Sakonsinsiri Timpika Chaiprasert Napat Armartmuntree Duangkamon Muengsaen Anchalee Techasen Poramate Klanrit Worachart Lert-itthiporn Somchai Pinlaor Chawalit Pairojkul |
2020 |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 5.0 (21.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model | Hasaya Dokduang Watcharin Loilome Nisana Namwat Anchalee Techasen Chawalit Pairojkul Narong Khuntikeo Yoshinori Murakami Puangrat Yongvanit |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 195 |
|
| 2. | Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression | Yingpinyapat Kittirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 133-135 |
|
| 3. | Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 138-140 |
|
| 4. | Gene Silencing of Translationally Controlled Tumor Protein (TCTP) | Nattaporn Phanthaphol Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 136-137 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ | ||
|---|---|---|---|---|---|---|
| 1. | แบบแผนเปบทีโดมิกส์ในปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง |
รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน ดร. สิทธิรักษ์ รอยตระกูล รศ.ดร.นพ. ณรงค์ ขันตีแก้ว รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร ศ.ดร. พวงรัตน์ ยงวณิชย์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | แบบแผนโปรทิโอมิกส์ในซีรัมของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง |
ศ.ดร. พวงรัตน์ ยงวณิชย์ อ.ดร. อัญชลี เตชะเสน ดร. สิทธิรักษ์ รอยตระกูล รศ.ดร.นพ. ณรงค์ ขันตีแก้ว รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร รศ.ดร. วัชรินทร์ ลอยลม |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 3. | แบบแผนไมโครอาร์เอ็นเอในซีรัมและปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยงของโรคมะเร็งท่อน้ำดี |
รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร นายชวลิต ไพโรจน์กุล ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 4. | กลไกการเปลี่ยนแปลงรูปร่างของเซลล์จากเยื่อบุผิวเป็นมีเซนไคม์ในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา |
อ.ดร. อัญชลี เตชะเสน ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม รศ.ดร. นิษณา นามวาท ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. เรณู ทานันท์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 5. | การควบคุมวิถีออโตฟาจีในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา |
รศ.ดร. นิษณา นามวาท รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ศ.ดร. พวงรัตน์ ยงวณิชย์ ผศ.ดร. เรณู ทานันท์ อ.ดร. อัญชลี เตชะเสน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 6. | การประเมินลายพิมพ์อินฟราเรดสเปคตรัมที่สัมพันธ์กับ การเกิดไฟโบรซิสเพื่อใช้เป็นตัวบ่งชี้แนวใหม่ในการติดตามการดำเนินของโรคมะเร็งท่อน้ำดี |
ผศ.ดร. อมรรัตน์ จำเนียรทรง รศ.ดร. พัชรี เจียรนัยกูร ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ รศ.ดร.นพ. ณรงค์ ขันตีแก้ว ผศ.ดร. พัชราภรณ์ ทิพยวัฒน์ นางนิชาดา เจียรนัยกูร อ.ดร. อัญชลี เตชะเสน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 7. | บทบาทของยีนก่อมะเร็งท่อน้ำดีในสภาวะความเครียดออกซิเดชันที่สัมพันธ์กับกระบวนการเหนือพันธุกรรมเพื่อการป้องกันและรักษาโรค |
ผศ.ดร. เรณู ทานันท์ ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร. สมชาย ปิ่นละออ อ.ดร. อัญชลี เตชะเสน รศ.ดร. นิษณา นามวาท นายชวลิต ไพโรจน์กุล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 8. | ยีนก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับโรคพยาธิใบไม้ตับ: เป้าหมายใหม่สำหรับการป้องกันและรักษา |
รศ.ดร. นิษณา นามวาท ผศ.ดร. เรณู ทานันท์ รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน ศ.ดร. สมชาย ปิ่นละออ |
ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 9. | ฤทธิ์ของสารยั้บยั้งวิถีการส่งสัญญาณของโปรตีนไคเนสเพื่อใช้ในการป้องกันและรักษาโรคมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน ผศ.ดร. เรณู ทานันท์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 10. | การประยุกต์ใช้เทคนิค histoculture drug response assays ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน อ.ดร. อภิญญา จุ๊สกุล นพ. อรรถพล ติตะปัญ ม.ล. มานิดา ศุขสวัสดิ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 11. | การพัฒนาชุดตรวจทางชีวภาพเพื่อใช้ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อภิญญา จุ๊สกุล รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |